Cargando…

An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms

The overlap of 94 single-nucleotide polymorphisms (SNP) among the 4,720 and 11,120 SNPs contained in the linkage panels of Illumina and Affymetrix, respectively, allows an assessment of the discrepancy rate produced by these two platforms. Although the no-call rate for the Affymetrix platform is app...

Descripción completa

Detalles Bibliográficos
Autores principales: Suarez, Brian K, Taylor, Chelsea, Bertelsen, Sarah, Bierut, Laura J, Dunn, Gerald, Jin, Carol H, Kauwe, John SK, Paterson, Andrew D, Hinrichs, Anthony L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866782/
https://www.ncbi.nlm.nih.gov/pubmed/16451613
http://dx.doi.org/10.1186/1471-2156-6-S1-S152
_version_ 1782133326980579328
author Suarez, Brian K
Taylor, Chelsea
Bertelsen, Sarah
Bierut, Laura J
Dunn, Gerald
Jin, Carol H
Kauwe, John SK
Paterson, Andrew D
Hinrichs, Anthony L
author_facet Suarez, Brian K
Taylor, Chelsea
Bertelsen, Sarah
Bierut, Laura J
Dunn, Gerald
Jin, Carol H
Kauwe, John SK
Paterson, Andrew D
Hinrichs, Anthony L
author_sort Suarez, Brian K
collection PubMed
description The overlap of 94 single-nucleotide polymorphisms (SNP) among the 4,720 and 11,120 SNPs contained in the linkage panels of Illumina and Affymetrix, respectively, allows an assessment of the discrepancy rate produced by these two platforms. Although the no-call rate for the Affymetrix platform is approximately 8.6 times greater than for the Illumina platform, when both platforms make a genotypic call, the agreement is an impressive 99.85%. To determine if disputed genotypes can be resolved without sequencing, we studied recombination in the region of the discrepancy for the most discrepant SNP rs958883 (typed by Illumina) and tsc02060848 (typed by Affymetrix). We find that the number of inferred recombinants is substantially higher for the Affymetrix genotypes compared to the Illumina genotypes. We illustrate this with pedigree 10043, in which 3 of 7 versus 0 of 7 offspring must be double recombinants using the genotypes from the Affymetrix and the Illumina platforms, respectively. Of the 36 SNPs with one or more discrepancies, we identified a subset that appears to cluster in families. Some of this clustering may be due to the presence of a second segregating SNP that obliterates a XbaI site (the restriction enzyme used in the Affymetrix platform), resulting in a fragment too long (>1,000 bp) to be amplified.
format Text
id pubmed-1866782
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18667822007-05-11 An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms Suarez, Brian K Taylor, Chelsea Bertelsen, Sarah Bierut, Laura J Dunn, Gerald Jin, Carol H Kauwe, John SK Paterson, Andrew D Hinrichs, Anthony L BMC Genet Proceedings The overlap of 94 single-nucleotide polymorphisms (SNP) among the 4,720 and 11,120 SNPs contained in the linkage panels of Illumina and Affymetrix, respectively, allows an assessment of the discrepancy rate produced by these two platforms. Although the no-call rate for the Affymetrix platform is approximately 8.6 times greater than for the Illumina platform, when both platforms make a genotypic call, the agreement is an impressive 99.85%. To determine if disputed genotypes can be resolved without sequencing, we studied recombination in the region of the discrepancy for the most discrepant SNP rs958883 (typed by Illumina) and tsc02060848 (typed by Affymetrix). We find that the number of inferred recombinants is substantially higher for the Affymetrix genotypes compared to the Illumina genotypes. We illustrate this with pedigree 10043, in which 3 of 7 versus 0 of 7 offspring must be double recombinants using the genotypes from the Affymetrix and the Illumina platforms, respectively. Of the 36 SNPs with one or more discrepancies, we identified a subset that appears to cluster in families. Some of this clustering may be due to the presence of a second segregating SNP that obliterates a XbaI site (the restriction enzyme used in the Affymetrix platform), resulting in a fragment too long (>1,000 bp) to be amplified. BioMed Central 2005-12-30 /pmc/articles/PMC1866782/ /pubmed/16451613 http://dx.doi.org/10.1186/1471-2156-6-S1-S152 Text en Copyright © 2005 Suarez et al; licensee BioMed Central Ltd http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Proceedings
Suarez, Brian K
Taylor, Chelsea
Bertelsen, Sarah
Bierut, Laura J
Dunn, Gerald
Jin, Carol H
Kauwe, John SK
Paterson, Andrew D
Hinrichs, Anthony L
An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms
title An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms
title_full An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms
title_fullStr An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms
title_full_unstemmed An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms
title_short An analysis of identical single-nucleotide polymorphisms genotyped by two different platforms
title_sort analysis of identical single-nucleotide polymorphisms genotyped by two different platforms
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866782/
https://www.ncbi.nlm.nih.gov/pubmed/16451613
http://dx.doi.org/10.1186/1471-2156-6-S1-S152
work_keys_str_mv AT suarezbriank ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT taylorchelsea ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT bertelsensarah ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT bierutlauraj ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT dunngerald ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT jincarolh ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT kauwejohnsk ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT patersonandrewd ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT hinrichsanthonyl ananalysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT suarezbriank analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT taylorchelsea analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT bertelsensarah analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT bierutlauraj analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT dunngerald analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT jincarolh analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT kauwejohnsk analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT patersonandrewd analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms
AT hinrichsanthonyl analysisofidenticalsinglenucleotidepolymorphismsgenotypedbytwodifferentplatforms